Pseudotime analysis of 2,106 brains across nine regions reveals conserved immune, neuronal, and myelin regulatory programs in Alzheimer's disease
Fabrizio EccaiD, Serena SongiD, Marcus NaymikiD, Matthew J. HuentelmaniD, Ignazio Stefano PirasiD
Abstract
Pseudotime trajectories can reconstruct latent disease progression from cross-sectional transcriptomic data. However, whether Alzheimer's disease (AD) progression follows a conserved molecular architecture across brain regions remains unclear. We applied pseudotime analysis to harmonized bulk RNA-seq data from 2,106 postmortem brain samples (1,364 AD, 742 controls) across nine brain regions from three AMP-AD cohorts (ROSMAP, Mayo, MSBB). Pseudotime was significantly associated with AD diagnosis in all nine regions and with Braak stage in seven of nine. We identified 21 genes with concordant pseudotime associations across all regions, increasing to 234 when the cerebellum was excluded. Pathway analysis revealed 1,268 significant associations, with synaptic deregulation as the most conserved process, and immune/ECM programs showing greater regional specificity. The cerebellum followed a distinct pattern, with enrichment for protein refolding and chaperone pathways rather than neurodegeneration. Co-expression network analysis identified six conserved metamodules, including immune/glial (MM1) and excitatory neuronal (MM2) programs spanning all nine regions, and an oligodendrocyte/myelin program (MM3) in seven cortical regions. Key driver analysis identified 76 unique genes across 35 modules, with HCK and LAPTM5 as the most broadly replicated immune regulators in seven regions. Oligodendrocyte-associated key drivers (MYRF, CNP, MOBP) increased along pseudotime in cortical regions, supporting active myelin remodeling during AD progression. These findings reveal a conserved transcriptional architecture underlying AD progression, organized around coordinated immune activation, synaptic loss, and myelin remodeling, with the cerebellum following a distinct trajectory.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-regional Neurodegeneration in Alzheimer’s disease: Meta-analysis and data integration of transcriptomics data
Reza Karbalaei, Mostafa Rezaei–Tavirani, … Sadegh Azimzadeh Jamalkandi·bioRxiv·Jan 9, 2018
- Molecular estimation of neurodegeneration pseudotime in older brains
Sumit Mukherjee, Laura M. Heath, … Benjamin A. Logsdon·Nature CommunicationsPeer-reviewed·Nov 13, 2020
- Cross-Regional Trajectory Analysis Reveals Distinct Temporal Progression of Shared Proteomic Programs in Alzheimer's Disease
Tianchuan Gao, Yurika Upadhyaya, … Jingwen Yan·bioRxiv·Aug 25, 2026
- Conserved Architecture of Brain Transcriptome Changes between Alzheimer's Disease and Progressive Supranuclear Palsy in Pathologically Affected and Unaffected Regions
Xue Wang, Mariet Allen, … Nilüfer Ertekin‐Taner·bioRxiv·Jan 18, 2021
- Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer's disease
Alberto Serrano‐Pozo, Zhaozhi Li, … Sudeshna Das·bioRxiv·Dec 3, 2022
- Multi-scale transcriptomic integration reveals cell-type immune networks and lncRNA remodeling in Alzheimers disease
Jonathan Alexis Cortes Silva, Michael Gertig, … André Fischer·bioRxiv·Feb 10, 2026